The latest price target for Beta Bionics (NASDAQ:BBNX) was reported by Stifel on February 24, 2025. The analyst firm set a price target for $25.00 expecting BBNX to rise to within 12 months (a possible 21.36% upside). 6 analyst firms have reported ratings in the last year.

The latest analyst rating for Beta Bionics (NASDAQ:BBNX) was provided by Stifel, and Beta Bionics initiated their buy rating.

There is no last upgrade for Beta Bionics

There is no last downgrade for Beta Bionics.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Beta Bionics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Beta Bionics was filed on February 24, 2025 so you should expect the next rating to be made available sometime around February 24, 2026.

While ratings are subjective and will change, the latest Beta Bionics (BBNX) rating was a initiated with a price target of $0.00 to $25.00. The current price Beta Bionics (BBNX) is trading at is $20.60, which is within the analyst’s predicted range.